Nanosphere Submits Cardiac Test to FDA

Nanosphere is seeking FDA clearance for the assay, which would be used to provide early diagnosis of myocardial infarction and risk stratification for acute coronary syndromes.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.